This pharmacological study indicates repetitive Transcranial magnetic stimulation alters brain connectivity in patients, suggesting optimizing treatments for psychiatric disorders.
The inhibitory effect of interhemispheric signal propagation (ISP) is believed to be aligned with GABAB receptor mediated inhibitory neurotransmission and related to interhemispheric connectivity. Repetitive Transcranial magnetic stimulation (rTMS) is a safe and potent strategy for altering brain connectivity. However, it remains unclear if rTMS modulates ISP. With pretreatment of baclofen, a GABAB receptor agonist, this study characterized rTMS effects on ISP and the influence of GABAB receptor neurotransmission. ISP was measured with TMS and electroencephalography co-registration (TMS-EEG). Excitatory rTMS (> 5 Hz) was found to increase interhemispheric inhibition indexed by ISP. This effect was reduced by baclofen pretreatment, potentially reflecting competition for GABAB receptors neurotransmission between baclofen and rTMS. Beyond evoked potentials, our data also identified TMS-evoked gamma oscillation as a reliable indicator of intracortical inhibition. These novel findings help to clarify the effects of rTMS on interhemispheric connectivity, which may help to optimize rTMS treatments for various psychiatric disorders.
No takes yet. Share an insight, caveat, or question.
Han et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: